Once valued at $4B, an embattled Akorn — nursing a market cap of roughly $37M — files for bankruptcy
Scarred by a series of FDA warnings, a scorned buyer and the uncertainty of Covid-19, Akorn is finally throwing in the towel.
On Wednesday, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
